177 related articles for article (PubMed ID: 29099538)
1. How immunologic and genetic biomarkers impact Hodgkin lymphoma classification, diagnosis, and management: a huge potential that yet needs to be exploited.
Carbone A; Gloghini A
Int J Biol Markers; 2018 May; 33(2):137-140. PubMed ID: 29099538
[TBL] [Abstract][Full Text] [Related]
2. The many faces of Hodgkin's disease around the world: what have we learned from its pathology?
Harris NL
Ann Oncol; 1998; 9 Suppl 5():S45-56. PubMed ID: 9926237
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: an immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells.
Di Napoli A; Al-Jadiri MF; Talerico C; Duranti E; Pilozzi E; Trivedi P; Anastasiadou E; Alsaadawi AR; Al-Darraji AF; Al-Hadad SA; Testi AM; Uccini S; Ruco L
Pediatr Blood Cancer; 2013 Dec; 60(12):2068-72. PubMed ID: 24000236
[TBL] [Abstract][Full Text] [Related]
4. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.
Wu D; Thomas A; Fromm JR
Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and pathologic features of Hodgkin lymphoma.
Nakatsuka S; Aozasa K
Int J Hematol; 2006 Jun; 83(5):391-7. PubMed ID: 16787868
[TBL] [Abstract][Full Text] [Related]
6. Molecular biology of Hodgkin lymphoma.
Küppers R
Hematology Am Soc Hematol Educ Program; 2009; ():491-6. PubMed ID: 20008234
[TBL] [Abstract][Full Text] [Related]
7. [Current views of the histogenesis and pathogenesis of Hodgkin lymphoma].
Leenman EE
Arkh Patol; 2007; 69(5):7-11. PubMed ID: 18074812
[TBL] [Abstract][Full Text] [Related]
8. Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma.
Xiao Q; Shen N; Hedvat CV; Moskowitz CH; Sussman LK; Filippa DA; Zelenetz AD; Houldsworth J; Chaganti RS; Teruya-Feldstein J
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):211-5. PubMed ID: 15551733
[TBL] [Abstract][Full Text] [Related]
9. Composite lymphoma of nodular lymphocyte-predominant and classical Hodgkin lymphoma-Epstein-Barr virus association suggests divergent pathogenesis despite clonal relatedness.
Szczepanowski M; Masqué-Soler N; Oschlies I; Schmidt W; Lück A; Klapper W
Hum Pathol; 2013 Jul; 44(7):1434-9. PubMed ID: 23427872
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus is associated with all histological subtypes of Hodgkin lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype.
Chang KC; Khen NT; Jones D; Su IJ
Hum Pathol; 2005 Jul; 36(7):747-55. PubMed ID: 16084943
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of Hodgkin's disease: an update on histopathological and immunophenotypical features.
Fraga M; Forteza J
Histol Histopathol; 2007 Aug; 22(8):923-35. PubMed ID: 17503349
[TBL] [Abstract][Full Text] [Related]
12. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
Wang E; Papavassiliou P; Sebastian S
Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
[TBL] [Abstract][Full Text] [Related]
13. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
14. The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis.
Carbone A; Gloghini A; Caruso A; De Paoli P; Dolcetti R
Int J Cancer; 2017 Mar; 140(6):1233-1245. PubMed ID: 27750386
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin's disease: classification and differential diagnosis.
Harris NL
Mod Pathol; 1999 Feb; 12(2):159-75. PubMed ID: 10071341
[TBL] [Abstract][Full Text] [Related]
16. Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases.
Loo EY; Medeiros LJ; Aladily TN; Hoehn D; Kanagal-Shamanna R; Young KH; Lin P; Bueso-Ramos CE; Manning JT; Patel K; Thomazy V; Brynes RK; Goswami M; Fayad LE; Miranda RN
Am J Surg Pathol; 2013 Aug; 37(8):1290-7. PubMed ID: 23774171
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin lymphoma: Pathology and biology.
Mathas S; Hartmann S; Küppers R
Semin Hematol; 2016 Jul; 53(3):139-47. PubMed ID: 27496304
[TBL] [Abstract][Full Text] [Related]
18. Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma.
Gandhi MK; Moll G; Smith C; Dua U; Lambley E; Ramuz O; Gill D; Marlton P; Seymour JF; Khanna R
Blood; 2007 Aug; 110(4):1326-9. PubMed ID: 17438085
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells.
Sakakibara A; Kohno K; Eladl AE; Klaisuwan T; Ishikawa E; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Kato S; Asano N; Nakamura S; Satou A
Histopathology; 2018 Jun; 72(7):1156-1163. PubMed ID: 29380399
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin lymphoma: an update on its biology with new insights into classification.
Mani H; Jaffe ES
Clin Lymphoma Myeloma; 2009 Jun; 9(3):206-16. PubMed ID: 19525189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
